EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Epigenetic regulation of sex dimorphism in cardiovascular health

Charan Thej iD, Raj Kishore iD

Canadian Journal of Physiology and Pharmacology · 01.09.2024 · 102 (9) · 498-510

DOI: 10.1139/cjpp-2023-0406 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Canadian Journal of Physiology and Pharmacology, erschienen am 01.09.2024. Verfasst von Charan Thej und 1 weiteren Autor:innen. Beteiligte Einrichtung: Aging and Cardiovascular Discovery Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 19140, USA. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Sex Characteristics, Cardiovascular Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality, affecting people of all races, ages, and sexes. Substantial sex dimorphism exists in the prevalence, manifestation, and outcomes of CVDs. Understanding the role of sex hormones as well as sex-hormone-independent epigenetic mechanisms could play a crucial role in developing effective and sex-specific cardiovascular therapeutics. Existing research highlights significant disparities in sex hormones, epigenetic regulators, and gene expression related to cardiac health, emphasizing the need for a nuanced understanding of these variations between men and women. Despite these differences, current treatment approaches for CVDs often lack sex-specific considerations. A pivotal shift toward personalized medicine, informed by comprehensive insights into sex-specific DNA methylation, histone modifications, and non-coding RNA dynamics, holds the potential to revolutionize CVD management. By understanding sex-specific epigenetic complexities, independent of sex hormone influence, future cardiovascular research can be tailored to achieve effective diagnostic and therapeutic interventions for both men and women. This review summarizes the current knowledge and gaps in epigenetic mechanisms and sex dimorphism implicated in CVDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticSex CharacteristicsCardiovascular DiseasesHumansGonadal Steroid HormonesDNA MethylationAnimalsFemaleMaleCardiovascular SystemSex Factors

Stichwörter der Autor:innen

cardiovascularepigeneticssex dimorphism

Substanzen

Gonadal Steroid Hormones

Autor:innen und Institutionen

  • Aging and Cardiovascular Discovery Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 19140, USA.
  • Department of Cardiovascular Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.

ORCID-Profile: Charan Thej, Raj Kishore

Förderung

  • NHLBI NIH HHS
  • National Institute of Health

Zitieren

APA

Thej, C., & Kishore, R. (2024). Epigenetic regulation of sex dimorphism in cardiovascular health. Canadian Journal of Physiology and Pharmacology, 102(9), 498-510. https://doi.org/10.1139/cjpp-2023-0406

Vancouver

Thej C, Kishore R. Epigenetic regulation of sex dimorphism in cardiovascular health. Canadian Journal of Physiology and Pharmacology. 2024;102(9):498-510. doi:10.1139/cjpp-2023-0406

BibTeX
@article{Thej2024,
  author = {Thej, Charan and Kishore, Raj},
  title = {Epigenetic regulation of sex dimorphism in cardiovascular health},
  journal = {Canadian Journal of Physiology and Pharmacology},
  year = {2024},
  volume = {102},
  number = {9},
  pages = {498--510},
  doi = {10.1139/cjpp-2023-0406}
}
Kostenlos starten →